Johnson & Johnson Option Alert: Oct 17 $175 Calls at the Bid: 1250 vs 16140 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Oct 17 $175 Calls at the Bid: 1250 @ $5.8 vs 16140 OI; Earnings 10/14 Before Open [est] Ref=$176.55

Johnson & Johnson Option Alert: Jan 16 $170 Puts at the Bid: 2000 vs 3699 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Jan 16 $170 Puts at the Bid: 2000 @ $3.7 vs 3699 OI; Earnings 10/14 Before Open [est] Ref=$178.66

Johnson & Johnson Option Alert: Nov 21 $170 Calls at the Ask: 599 vs 516 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Nov 21 $170 Calls at the Ask: 599 @ $12.2 vs 516 OI; Earnings 10/14 Before Open [est] Ref=$179.165

Johnson & Johnson Option Alert: Nov 21 $175 Calls Sweep (14) near the Bid: 755 vs 2233 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Nov 21 $175 Calls Sweep (14) near the Bid: 755 @ $8.901 vs 2233 OI; Earnings 10/14 Before Open [est] Ref=$179.47

Johnson & Johnson Option Alert: Nov 21 $175 Calls Sweep (8) near the Ask: 650 vs 2233 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Nov 21 $175 Calls Sweep (8) near the Ask: 650 @ $8.951 vs 2233 OI; Earnings 10/14 Before Open [est] Ref=$179.51

Johnson & Johnson Option Alert: Sep 19 $175 Calls at the Bid: 1000 vs 12331 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Sep 19 $175 Calls at the Bid: 1000 @ $5.57 vs 12331 OI; Earnings 10/14 Before Open [est] Ref=$179.55

Johnson & Johnson Option Alert: Nov 21 $170 Calls Sweep (11) near the Ask: 567 vs 516 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Nov 21 $170 Calls Sweep (11) near the Ask: 567 @ $12.901 vs 516 OI; Earnings 10/14 Before Open [est] Ref=$180.09

Johnson & Johnson Option Alert: Oct 17 $170 Calls Sweep (15) near the Ask: 1075 vs 10167 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Oct 17 $170 Calls Sweep (15) near the Ask: 1075 @ $11.6 vs 10167 OI; Earnings 10/14 Before Open [est] Ref=$180.24

Johnson & Johnson Option Alert: Oct 17 $170 Calls Sweep (13) near the Ask: 500 vs 10167 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Oct 17 $170 Calls Sweep (13) near the Ask: 500 @ $11.6 vs 10167 OI; Earnings 10/14 Before Open [est] Ref=$180.19

Johnson & Johnson Option Alert: Sep 19 $170 Calls Sweep (33) near the midpoint: 877 vs 22785 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Sep 19 $170 Calls Sweep (33) near the midpoint: 877 @ $11.096 vs 22785 OI; Earnings 10/14 Before Open [est] Ref=$180.99

Johnson & Johnson Option Alert: Aug 29 $170 Calls Sweep (4) near the Ask: 1500 vs 2201 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Aug 29 $170 Calls Sweep (4) near the Ask: 1500 @ $10.765 vs 2201 OI; Earnings 10/14 Before Open [est] Ref=$180.535

Johnson & Johnson Option Alert: Sep 19 $165 Calls at the Ask: 1000 vs 17905 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Sep 19 $165 Calls at the Ask: 1000 @ $14.57 vs 17905 OI; Earnings 10/14 Before Open [est] Ref=$179.36

Johnson & Johnson Option Alert: Oct 17 $175 Calls at the Bid: 1000 vs 12524 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Oct 17 $175 Calls at the Bid: 1000 @ $7.22 vs 12524 OI; Earnings 10/14 Before Open [est] Ref=$179.36

Johnson & Johnson Option Alert: Jul 17 $175 Puts at the Bid: 1000 vs 11 OI; Earnings 10/14 Before Open [est] 

Johnson & Johnson Option Alert: Jul 17 $175 Puts at the Bid: 1000 @ $9.28 vs 11 OI; Earnings 10/14 Before Open [est] Ref=$178.7

Johnson & Johnson

JOHNSON & JOHNSON

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Gradient,Of,Fabric,Usa,American,And,Eu,European,Union,Flags,

Equities

News

Markets

General

TSLA

EE.UU. y la UE negocian eliminar aranceles industriales. Exportadores como Caterpillar, Boeing, Tesla y Pfizer serían los más beneficiados.

EE.UU. y UE avanzan hacia un acuerdo arancelario: impacto en Caterpillar, Boeing y Tesla

manufacturing PMI

Long Ideas

Trading Ideas

AAPL

NVDA

Apple, Nvidia, TSMC y otras grandes empresas están trayendo su producción de vuelta a EE. UU. en una nueva ola de relocalización.

Gigantes tecnológicos y fabricantes de EE. UU. apuestan por relocalizar su producción: ¿Vuelve el &#34;Made in USA&#34;?

Jim Cramer

ABBV

Jim Cramer advierte que el aumento de los rendimientos del Tesoro hace que los bonos sean más atractivos que las acciones defensivas.

Jim Cramer: Por qué los bonos son más seguros que las acciones defensivas

Press Releases

Dean Omar Branham Shirley Attorney Named Among Nation's Top Future Legal Leaders

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer

Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasis

Opinion

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

Johnson & Johnson showcases latest advancements in Alzheimer's research at AAIC 2025

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

AVAI

BLCO

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Perrigo

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

Citigroup

Barclays

RBC Capital

Guggenheim

Screenshot 2025-07-10 at 8.34.03 PM

Biotech

KERX

When it comes to unmet needs in the nephrology space, acute kidney injury remains a significant concern.

SeaStar Medical&#39;s QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka

Screenshot 2024-09-30 at 9.13.36 PM

TNXP

VRTX

The Rush For Non-Addictive Painkillers To Counter The Opioid Crisis Puts Two Companies Closer To FDA Decisions

Screenshot 2024-04-30 at 5.36.02 PM

Health Care

Cardio Diagnostics Holdings Inc. - Common stock

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
11:02 AMAug 26, 2025	CALL	$175.00	Oct 17, 2025	49	1360	1250	8	16140	TRADE	BEARISH
10:51 AMAug 25, 2025	PUT	$170.00	Jan 16, 2026	140	2461	2000	67	3699	TRADE	BEARISH
01:35 PMAug 22, 2025	CALL	$170.00	Nov 21, 2025	84	1941	599	376	516	TRADE	BULLISH
10:18 AMAug 22, 2025	CALL	$175.00	Nov 21, 2025	84	2546	755	114	2233	SWEEP	BEARISH
10:17 AMAug 22, 2025	CALL	$175.00	Nov 21, 2025	84	901	650	40	2233	SWEEP	BULLISH
10:08 AMAug 22, 2025	CALL	$175.00	Sep 19, 2025	21	19	1000	0	12331	TRADE	NEUTRAL
10:07 AMAug 22, 2025	CALL	$170.00	Nov 21, 2025	84	1200	567	233	516	SWEEP	BULLISH
10:07 AMAug 22, 2025	CALL	$170.00	Oct 17, 2025	49	876	1075	9	10167	SWEEP	BULLISH
10:07 AMAug 22, 2025	CALL	$170.00	Oct 17, 2025	49	351	500	3	10167	SWEEP	BULLISH
10:02 AMAug 22, 2025	CALL	$170.00	Sep 19, 2025	21	64	877	0	22785	SWEEP	NEUTRAL
10:00 AMAug 22, 2025	CALL	$170.00	Aug 29, 2025	0	7	1500	0	2201	SWEEP	BULLISH
03:45 PMAug 20, 2025	CALL	$165.00	Sep 19, 2025	21	1069	1000	6	17905	TRADE	BULLISH
03:45 PMAug 20, 2025	CALL	$175.00	Oct 17, 2025	49	1956	1000	16	12524	TRADE	BEARISH
12:22 PMAug 20, 2025	PUT	$175.00	Jul 17, 2026	322	1003	1000	9118	11	TRADE	NEUTRAL

Comments

Johnson & Johnson

Unusual Options Activity for

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL